Medical Disclaimer: This content is intended for informational purposes only and should not be considered medical advice. Cannabinoids are not approved for the treatment of infectious diseases, and the findings discussed are based largely on preclinical research. Do not use cannabis or cannabinoid products as a substitute for professional medical care.
The world stands on the verge of another pandemic, and this time it will not arise from a new virus, but from infections we can no longer treat. By 2050, drug-resistant infections are projected to kill up to 10 million people annually, surpassing cancer and outpacing the medical systems designed to control them. Pathogenic microorganisms are evolving like seasoned strategists, rewriting their genetic playbooks to survive and evade the medications that once stopped them with ease.
For years, antibiotics have been dispensed like miracle pills, prescribed for everything from sore throats to runny noses. In agriculture, they are mixed into livestock feed to help animals grow faster and survive in crowded farm conditions.
In hospital wards, doctors have noticed something unsettling. Infections that once resolved in days now linger. Patients returning with illnesses that look familiar but no longer respond to the same treatments. Methicillin-Resistant Staphylococcus aureus (MRSA) has swept through hospitals, thriving where disinfectants fail.
Carbapenem-resistant Enterobacteriaceae (CRE) appeared in ICU units, earning the title “nightmare bacteria” for their ability to resist nearly every antibiotic on record.
Pseudomonas haunted ventilators and surgical equipment. Drug-resistant tuberculosis re-emerged like a ghost from medical history, harder to treat than ever before. VRE (Vancomycin-resistant Enterococci) haveemerged in ICUs, defeating one of the strongest antibiotics in our arsenal and turning routine infections into medical crises.
As the world confronts antimicrobial resistance, researchers are increasingly exploring plant-based compounds for their potential antimicrobial properties. Yet many of these plants remain heavily restricted, limiting research, clinical trials, and …
Read More
Author: Daniel Gana / High Times
